Literature DB >> 21098311

Maternal cardiac dysfunction and remodeling in women with preeclampsia at term.

Karen Melchiorre1, George Ross Sutherland, Aigul Baltabaeva, Marco Liberati, Basky Thilaganathan.   

Abstract

Preeclampsia is a disease associated with significant cardiovascular morbidity during pregnancy and in later life. This study was designed to evaluate cardiac function and remodeling in preeclampsia occurring at term. This was a prospective case-control study of 50 term preeclampsia and 50 normal pregnancies assessed by echocardiography and tissue Doppler analysis. Global diastolic dysfunction was observed more frequently in preeclampsia versus control pregnancies (40% versus 14%, P = 0.007). Increased cardiac work and left ventricular mass indices suggest that left ventricular remodeling was an adaptive response to maintain myocardial contractility with preeclampsia at term. Approximately 20% of patients with preeclampsia at term have more evident myocardial damage. Diastolic dysfunction usually precedes systolic dysfunction in the evolution of ischemic or hypertensive cardiac diseases and is of prognostic value in the prediction of long-term cardiovascular morbidity. The study findings also have significant implications for the acute medical management of preeclampsia.

Entities:  

Mesh:

Year:  2010        PMID: 21098311     DOI: 10.1161/HYPERTENSIONAHA.110.162321

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  62 in total

1.  Quantitative evaluation of longitudinal strain in layer-specific myocardium in patients with preeclampsia.

Authors:  Juan Cong; Yong Lee; Xiuxiu Fu; Zhibin Wang; Wugang Wang; Junfang Lee
Journal:  Int J Cardiovasc Imaging       Date:  2017-08-03       Impact factor: 2.357

Review 2.  16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Ingrid Struman; Melanie Hoch; Edith Podewski; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2012-09

3.  Acute Cardiac Effects of Severe Pre-Eclampsia.

Authors:  Arthur Jason Vaught; Lara C Kovell; Linda M Szymanski; Susan A Mayer; Sara M Seifert; Dhananjay Vaidya; Jamie D Murphy; Cynthia Argani; Anna O'Kelly; Sarah York; Pamela Ouyang; Monica Mukherjee; Sammy Zakaria
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

4.  Echoes of Preeclampsia: Can Echocardiography Help Predict Recurrence?

Authors:  Eliyahu V Khankin; Zoltan Arany
Journal:  Hypertension       Date:  2016-02-22       Impact factor: 10.190

5.  Maternal cardiac remodeling and dysfunction in preeclampsia: a three-dimensional speckle-tracking echocardiography study.

Authors:  Juan Cong; Tingpan Fan; Xiaoqian Yang; Jacson Shen; Guomei Cheng; Zhan Zhang
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-16       Impact factor: 2.357

6.  Quantitative analysis of left atrial volume and function during normotensive and preeclamptic pregnancy: a real-time three-dimensional echocardiography study.

Authors:  Juan Cong; Xiaoqian Yang; Nan Zhang; Jacson Shen; Tingpan Fan; Zhan Zhang
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-22       Impact factor: 2.357

Review 7.  How does preeclampsia predispose to future cardiovascular disease?

Authors:  Dawn C Scantlebury; Sharonne N Hayes
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

8.  Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.

Authors:  JoonHo Lee; Roberto Romero; Zhong Dong; Deug-Chan Lee; Yi Dong; Pooja Mittal; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

9.  Ecalmpsia: maternal and fetal outcome.

Authors:  Tukur A Jido
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 10.  The treatment of hypertension during pregnancy: when should blood pressure medications be started?

Authors:  Dawn C Scantlebury; Gary L Schwartz; Letitia A Acquah; Wendy M White; Marvin Moser; Vesna D Garovic
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.